Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: NutraMax

This article was originally published in The Tan Sheet

Executive Summary

NutraMax: Forms special committee of its board to "explore strategic alternatives" for the company after MEDIQ announced in November that it may sell its 47% share of the private-labeler, NutraMax said June 19. The committee has hired Wasserstein Perella & Co. as financial advisors. Separately, NutraMax released expected earnings for the third quarter (ending June 30) of $.10-.11 per share, down from $.14 per share last year, due to "continued softness" in cough/cold sales from the mild winter. A backlog of customer cough/cold orders and new eye care product sales should help fuel a recovery in the fourth quarter, the firm said. Early sales of NutraMax's newest line, NutraMax Plus High Calorie Liquid Nutrition, are "very positive," the firm noted; three additional items are slated to be introduced in early fall...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083963

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel